Sam Kay
About Sam Kay
Sam Kay serves as the Vice President of Pharma at Basil Systems, where he focuses on data integration strategies to enhance product development. With over 10 years of experience in the pharmaceutical and med-tech industries, he leads a team dedicated to transforming medical product development through AI and Machine Learning.
Work at Basil Systems
Sam Kay serves as the Vice President of Pharma at Basil Systems, a position held since 2024. In this role, he leads a team focused on transforming medical product development through the application of artificial intelligence and machine learning. His responsibilities include pioneering data integration strategies aimed at enhancing speed to market and refining product strategies. Kay's leadership is instrumental in delivering innovative solutions that address the complexities of the pharmaceutical industry.
Education and Expertise
Sam Kay obtained a Master’s Degree in Pharmacy from Kingston University, where he studied from 2012 to 2016. He also holds a CeMAP qualification in Mortgage Advice and Protection from the Institute of Financial Studies, completed in 2012. Additionally, he earned a DipFA in Financial Planning and Services from The Chartered Insurance Institute. With over 10 years of experience in the pharmaceutical and med-tech industries, Kay possesses a deep understanding of regulatory, clinical, and financial aspects.
Background
Before joining Basil Systems, Sam Kay worked at Clarivate as a Principal Regulatory Consultant from 2020 to 2024. He also held the position of Regulatory Intelligence Lead at Gilead Sciences from 2019 to 2020. Earlier in his career, he worked as a Consultant at PwC for 11 months in 2018. His diverse background in consulting and regulatory roles has equipped him with the skills necessary to navigate complex projects and collaborate effectively with health authorities.
Achievements
Throughout his career, Sam Kay has successfully managed complex projects and collaborated with leading health authorities. His work has provided strategic guidance to top pharmaceutical companies, contributing to advancements in the industry. Kay is passionate about leveraging comprehensive data insights to set new benchmarks and improve patient lives, reflecting his commitment to enhancing healthcare outcomes.